Apogee Therapeutics (APGE)
$54.25
Apogee Therapeutics (APGE) Share Price Forecast
Currently 12 wall-street analysts regularly analyze the financials of Apogee Therapeutics on a frequent basis to provide recommendations along with target share price. 12 analysts offering 12-month price forecasts for Apogee Therapeutics (APGE) have a share price target of $85.5. This median of share price forecast represents a 57.6% upside from the latest price of $54.25 as on 11.10.24.
Apogee Therapeutics (APGE) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Apogee Therapeutics (APGE) share price will touch around $85.5 in next 12-months.
Apogee Therapeutics (APGE) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Apogee Therapeutics's share price and its median forecast price. As on 11.10.24, the difference is -32.97%
Apogee Therapeutics (APGE): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Apogee Therapeutics (APGE) Share Price : Analyst Recommendation
Based on 12 analysts tracking and researching Apogee Therapeutics (APGE) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 4 | 4 | 4 |
| Outperform | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Apogee Therapeutics (APGE) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Apogee Therapeutics (APGE) is $85.5, offered by 12 analysts offering 12-month price forecasts.
Apogee Therapeutics (APGE) has a maximum of 0.58 upside potential, based on 12 analysts offering 12-month price forecasts.
Based on 12 analysts tracking and researching Apogee Therapeutics (APGE), 91.67% have a buy recommendation. Remaining 8.33% have either sell or hold recommendations.
The latest share price of Apogee Therapeutics (APGE) is $54.25 as of 11/10/2024.
11 of total 12 analysts offering stock ratings for Apogee Therapeutics APGE have recommended buy rating.
â‚ą0 US Stocks a/c Opening Fee